You are here

  • Home
  • Archive
  • Volume 66, Issue 3
  • Immunogenicity and safety profile of the monovalent A/H1N1 MF59-adjuvanted vaccine in patients affected by cystic fibrosis

Article Text

Article menu
Download PDFPDF
PostScript
Letter
Immunogenicity and safety profile of the monovalent A/H1N1 MF59-adjuvanted vaccine in patients affected by cystic fibrosis

https://doi.org/10.1136/thx.2010.156018

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests None.

    • Ethics approval This study was conducted with the approval of the Bambino Gesù Children's Hospital Ethic Committee.

    • Provenance and peer review Not commissioned; not externally peer reviewed.

    Linked Articles